177 related articles for article (PubMed ID: 22471890)
1. Prognostic impact of mRNA levels of osteopontin splice variants in soft tissue sarcoma patients.
Hahnel A; Wichmann H; Greither T; Kappler M; Würl P; Kotzsch M; Taubert H; Vordermark D; Bache M
BMC Cancer; 2012 Apr; 12():131. PubMed ID: 22471890
[TBL] [Abstract][Full Text] [Related]
2. Elevated tumor and serum levels of the hypoxia-associated protein osteopontin are associated with prognosis for soft tissue sarcoma patients.
Bache M; Kappler M; Wichmann H; Rot S; Hahnel A; Greither T; Said HM; Kotzsch M; Würl P; Taubert H; Vordermark D
BMC Cancer; 2010 Apr; 10():132. PubMed ID: 20377868
[TBL] [Abstract][Full Text] [Related]
3. Expression analysis of osteopontin mRNA splice variants in prostate cancer and benign prostatic hyperplasia.
Tilli TM; Thuler LC; Matos AR; Coutinho-Camillo CM; Soares FA; da Silva EA; Neves AF; Goulart LR; Gimba ER
Exp Mol Pathol; 2012 Feb; 92(1):13-9. PubMed ID: 21963599
[TBL] [Abstract][Full Text] [Related]
4. Distinctive Prognostic Value and Cellular Functions of Osteopontin Splice Variants in Human Gastric Cancer.
Hao C; Cui Y; Lane J; Jia S; Ji J; Jiang WG
Cells; 2021 Jul; 10(7):. PubMed ID: 34359989
[TBL] [Abstract][Full Text] [Related]
5. A novel splice variant of the stem cell marker LGR5/GPR49 is correlated with the risk of tumor-related death in soft-tissue sarcoma patients.
Rot S; Taubert H; Bache M; Greither T; Würl P; Eckert AW; Schubert J; Vordermark D; Kappler M
BMC Cancer; 2011 Oct; 11():429. PubMed ID: 21978106
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of the upregulated osteopontin mRNA expression in human colorectal cancer.
Likui W; Hong W; Shuwen Z
J Gastrointest Surg; 2010 Jan; 14(1):74-81. PubMed ID: 19763701
[TBL] [Abstract][Full Text] [Related]
7. Association of osteopontin with specific prognostic factors and survival in adjuvant breast cancer trials of the Hellenic Cooperative Oncology Group.
Psyrri A; Kalogeras KT; Wirtz RM; Kouvatseas G; Karayannopoulou G; Goussia A; Zagouri F; Veltrup E; Timotheadou E; Gogas H; Koutras A; Lazaridis G; Christodoulou C; Pentheroudakis G; Economopoulou P; Laskarakis A; Arapantoni-Dadioti P; Batistatou A; Sotiropoulou M; Aravantinos G; Papakostas P; Kosmidis P; Pectasides D; Fountzilas G
J Transl Med; 2017 Feb; 15(1):30. PubMed ID: 28193231
[TBL] [Abstract][Full Text] [Related]
8. [Expression of osteopontin splice variant and its clinical significance in gastric cancer].
Sun X; Wang L; Hou W; Li Y; Liu L; Zuo W; Yu J
Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):427-30. PubMed ID: 26463145
[TBL] [Abstract][Full Text] [Related]
9. Low HIF-1α and low EGFR mRNA Expression Significantly Associate with Poor Survival in Soft Tissue Sarcoma Patients; the Proteins React Differently.
Rot S; Taubert H; Bache M; Greither T; Würl P; Holzhausen HJ; Eckert AW; Vordermark D; Kappler M
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30513863
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Significance of Thrombomodulin mRNA in High-Grade Soft Tissue Sarcomas after 10 years.
Asanuma K; Nakamura T; Asanuma Y; Okamoto T; Kakimoto T; Yada Y; Hagi T; Kita K; Nakamura K; Matsumine A; Sudo A
Orthop Surg; 2020 Dec; 12(6):1726-1732. PubMed ID: 33015987
[TBL] [Abstract][Full Text] [Related]
11. Osteopontin splice variants differentially exert clinicopathological features and biological functions in gastric cancer.
Tang X; Li J; Yu B; Su L; Yu Y; Yan M; Liu B; Zhu Z
Int J Biol Sci; 2013; 9(1):55-66. PubMed ID: 23289017
[TBL] [Abstract][Full Text] [Related]
12. High bad and bcl-xL gene expression and combined bad, bcl-xL, bax and bcl-2 mRNA levels: molecular predictors for survival of stage 2 soft tissue sarcoma patients.
Köhler T; Würl P; Meye A; Lautenschläger C; Bartel F; Borchert S; Bache M; Schmidt H; Holzhausen HJ; Taubert H
Anticancer Res; 2002; 22(3):1553-9. PubMed ID: 12168836
[TBL] [Abstract][Full Text] [Related]
13. Expression pattern of osteopontin splice variants and its functions on cell apoptosis and invasion in glioma cells.
Yan W; Qian C; Zhao P; Zhang J; Shi L; Qian J; Liu N; Fu Z; Kang C; Pu P; You Y
Neuro Oncol; 2010 Aug; 12(8):765-75. PubMed ID: 20511184
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of Osteopontin Splice Variant-c Expression in Breast Cancers: A Meta-Analysis.
Hao C; Wang Z; Gu Y; Jiang WG; Cheng S
Biomed Res Int; 2016; 2016():7310694. PubMed ID: 27462610
[TBL] [Abstract][Full Text] [Related]
15. The role of osteopontin expression in melanoma progression.
Kiss T; Ecsedi S; Vizkeleti L; Koroknai V; Emri G; Kovács N; Adany R; Balazs M
Tumour Biol; 2015 Sep; 36(10):7841-7. PubMed ID: 25944164
[TBL] [Abstract][Full Text] [Related]
16. Inverse prognostic impact of ErbB2 mRNA and protein expression level in tumors of soft tissue sarcoma patients.
Wichmann H; Güttler A; Bache M; Taubert H; Vetter M; Würl P; Holzhausen HJ; Eckert AW; Kappler M; Vordermark D
Strahlenther Onkol; 2014 Oct; 190(10):912-8. PubMed ID: 24715245
[TBL] [Abstract][Full Text] [Related]
17. Myocardial Expression Analysis of Osteopontin and Its Splice Variants in Patients Affected by End-Stage Idiopathic or Ischemic Dilated Cardiomyopathy.
Cabiati M; Svezia B; Matteucci M; Botta L; Pucci A; Rinaldi M; Caselli C; Lionetti V; Del Ry S
PLoS One; 2016; 11(8):e0160110. PubMed ID: 27479215
[TBL] [Abstract][Full Text] [Related]
18. Elevated expression of survivin-splice variants predicts a poor outcome for soft-tissue sarcomas patients.
Taubert H; Kappler M; Bache M; Bartel F; Köhler T; Lautenschläger C; Blümke K; Würl P; Schmidt H; Meye A; Hauptmann S
Oncogene; 2005 Aug; 24(33):5258-61. PubMed ID: 15856009
[TBL] [Abstract][Full Text] [Related]
19. Combined mRNA expression levels of members of the urokinase plasminogen activator (uPA) system correlate with disease-associated survival of soft-tissue sarcoma patients.
Kotzsch M; Magdolen V; Greither T; Kappler M; Bache M; Lautenschläger C; Füssel S; Eckert AW; Luther T; Baretton G; Würl P; Taubert H
BMC Cancer; 2011 Jun; 11():273. PubMed ID: 21702998
[TBL] [Abstract][Full Text] [Related]
20. Osteopontin and splice variant expression level in human malignant glioma: radiobiologic effects and prognosis after radiotherapy.
Güttler A; Giebler M; Cuno P; Wichmann H; Keßler J; Ostheimer C; Söling A; Strauss C; Illert J; Kappler M; Vordermark D; Bache M
Radiother Oncol; 2013 Sep; 108(3):535-40. PubMed ID: 23891093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
